São Paulo, April 29, 2019 – The first edition of EmergeLabs Eurofarma is live! It will select up to 16 teams from all over Latin America that seek to take their research projects from the bench to the market. Submissions can be made through the website http://emerge.org.br/ until May 31.

 

The program has been in place since 2017 and Eurofarma, one of Brazil’s most innovative pharmaceutical companies, with a presence in 20 countries, is supporting the initiative by reinforcing its commitment to the development of the innovation ecosystem. “We believe in the union of science and technology with innovation. Several scientists and researchers work to reach society through their research and, with this program, we are offering the possibility of being the vectors of this transformation,” said Martha Penna, Vice President of Innovation at Eurofarma.

 

“EmergeLabs Eurofarma is a program developed especially for those who wish to take their research or technology from the laboratory to the market, generating impact and revenue. Our main goal is to provide a deep experience in innovation, entrepreneurship, market, intellectual property, team building, and other specially developed topics,” added Guilherme Rosso, President of Emerge.

 

The Program – Up to 16 teams will be selected with at least two members and a maximum of five, including at least one scientist or researcher. Students and researchers at the undergraduate, Master’s, Doctoral or Postdoctoral level can participate in the program, as well as entrepreneurs and managers, irrespective of their level of expertise – the potential impact of the team and the project is what counts instead.

 

The program is divided into the selection process (registration, evaluation, and interviews), five face-to-face stages, mentoring, and follow-up. The face-to-face meetings will be held at the School of Economics, Administration and Accounting (FEA) of the University of São Paulo (USP).

 

The projects will be evaluated according to the following criteria:

  • Impact: Projects that can significantly change people’s lives and work or the functioning of organizations, or projects with a global impact, as opposed to an impact just on a research area;
  • Creativity: The way in which applicants face problems and develop real solutions;
  • Audacity: Audacious people with a history of deeds, with wins and losses, and a continuous spirit of perseverance;
  • Current: Focus on what they are doing today, not on the projects they conducted in the past;
  • Communication: Clear ideas to be communicated and explained successfully in order to reach funders, consumers and the general public.

 

The announcement of the selected teams will take place on June 13. The results of each stage and the calls for subsequent steps will be communicated by email. On some occasions, as needed, telephone contacts will be made.

 

“We wish to broaden the relationship with the scientific and academic community, establishing new milestones for society. We believe in the potential and capacity of Latin American researchers and are willing to support the development of science in the region,” concluded Martha Penna.

 

To learn more, please visit http://emerge.org.br/.

 

 

About Eurofarma

 

The Eurofarma Group is a healthcare company focusing on offering products and services to improve people’s lives with quality, innovation and fair prices in the areas of Prescription, OTC, Generic, Hospital, Oncology and Veterinary medicines. In Brazil alone, the company offers 287 products in 622 presentations, serves 30 medical specialties and covers 101 therapeutic classes, which account for 89% of pharmaceutical retail sales.

 

Founded in 1972 and the first multinational pharmaceutical company with 100% Brazilian capital, it has its own operations in 20 countries, maintaining an important industrial park in Brazil and plants in 6 other Latin American countries. In 2018, the group achieved R$4.3 billion in sales, with over 6,700 employees.

 

For more information, please visit www.eurofarma.com.br.

 

Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram: @eurofarma_br

 

 

Press Information

G&A Relações Públicas – André Pascowitch +55 11 5090-8600 ext. 8369 – andre@gaspar.com.br

Guilherme Gaspar +55 11 3065-3045 – guilherme@gaspar.com.br

 

 

About Emerge

 

Established in 2016, Emerge – a non-profit organization – was created to foster and strengthen market-oriented technological innovation in Brazil, focusing especially on the emerging community of entrepreneurial scientists. www.emerge.org.br.

 

Facebook: @emergebrasil | LinkedIn: @emergebrasil | Instagram: @emerge.brasil

 

 

Press Information

Daniel Pimentel – Daniel.pimentel@emerge.org.br – +55 11 9 97355 9475